CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
48.56
+0.15 (0.31%)
At close: May 18, 2026, 4:00 PM EDT
48.28
-0.28 (-0.58%)
Pre-market: May 19, 2026, 5:59 AM EDT
CRISPR Therapeutics AG (CRSP) Operating Expense Breakdown
History
| Date | Research and Development | Collaboration | General and Administrative |
|---|---|---|---|
| Dec 31, 2025 | 284.81M | 213.48M | 73.54M |
| Sep 30, 2025 | 283.44M | 170.19M | 73.27M |
| Jun 30, 2025 | 306.69M | 124.23M | 73.76M |
| Mar 31, 2025 | 316.96M | 131.21M | 74.32M |
| Dec 31, 2024 | 320.65M | 120.67M | 72.98M |
| Sep 30, 2024 | 333.64M | 130.25M | 71.33M |
| Jun 30, 2024 | 342.18M | 142.52M | 72.20M |
| Mar 31, 2024 | 363.57M | 135.02M | 71.76M |
| Dec 31, 2023 | 387.33M | 130.25M | 76.16M |
| Sep 30, 2023 | 395.74M | 117.07M | 80.85M |
| Jun 30, 2023 | 421.67M | 132.51M | 89.56M |
| Mar 31, 2023 | 443.34M | 121.80M | 96.80M |
| Dec 31, 2022 | 461.65M | 110.25M | 102.46M |
| Sep 30, 2022 | 461.19M | 135.25M | 104.97M |
| Jun 30, 2022 | 428.06M | 118.86M | 101.68M |
| Mar 31, 2022 | 387.17M | 111.88M | 104.21M |
| Dec 31, 2021 | 339.55M | 101.18M | 100.71M |
| Sep 30, 2021 | 318.82M | 69.35M | 102.80M |
| Jun 30, 2021 | 306.33M | 46.89M | 100.63M |
| Mar 31, 2021 | 283.37M | 19.95M | 93.18M |
Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.